"There is no risk of a systemic lack of medicines in Poland", reassures the Deputy Minister of Health Maciej Miłkowski in response to the intervention of the Ombudsman Marcin Wiącek in connection with reports of difficulties in accessing morphine medicines. Let us remind you that signals about problems with the availability of morphine have been appearing for several weeks. Drugs with this substance are needed especially in the group of cancer patients. Therefore, the Ombudsman for Citizens' Rights, Marcin Wiącek, sent a letter to the Minister of Health in which he asks about actions taken to improve the situation. Minister Adam Niedzielski referred to the matter during the press conference. As he said, the problem results from the disruption of the supply chain as a result of Brexit, as a result of which production had to be moved from Great Britain to Germany. As announced, deliveries are to be restored later this year. Now the official reply to the Ombudsman's letter has been issued by Deputy Minister of Health Maciej Miłkowski. "The Minister of Health undertakes all necessary actions and interventions with regard to the tools at his disposal, however, the emergence of market shortages of individual drugs is not always predictable, and largely depends on random factors", we read in the letter.
The National Oncology Strategy assumed the start of HPV vaccination in 2021. for girls, which, despite many assurances, did not happen. Although a vaccine is now available with a 50% fee, the lack of education results in very little interest in the above-mentioned vaccine. vaccination.
We asked Senator Beata Małecka-Libera whether HPV vaccinations are on the agenda of the Senate Health Committee. The interview can be viewed on Medexpress.pl
Young people, women, the unemployed and people struggling with financial problems are, according to the report of the Organization for Economic Cooperation and Development and the European Commission, most at risk of depression. In Poland, the percentage of adults who remain at risk of depression may reach two-thirds. More on this subject on our website.
MZ expands the catalog of people who independently perform tests in the field of transfusion immunology. A Draft regulation in this matter was submitted for consultation. Changes in the regulation will include shortening the observation time to 12 hours and hospitalization of recipients of blood and its components. This will reduce the burden on medical entities performing the transfusion procedure. It will also increase the accessibility of hospitals for patients (both treated with blood and those requiring other treatments).